Recherche PDF


Cet outil permet de trouver un fichier parmi les documents publics partagés par les utilisateurs de Fichier-PDF.fr.
Dernière mise à jour de la base de données: 28 janvier à 23:02 - Environ 390000 fichiers indexés.

Afficher résultats par page

Réponses pour «acute»:



Total: 500 résultats - 0.061 secondes

100% - CMR

1B Acute Tox. 2 * Acute Tox. ... 1B Acute Tox.

https://www.fichier-pdf.fr/2016/03/10/cmr/

10/03/2016 www.fichier-pdf.fr



99% - The Vaccine Adverse Event Reporting System (VAERS) Results Form (1)

28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form CDC WONDER FAQs Help Contact Us WONDER Search The Vaccine Adverse Event Reporting System (VAERS) Results Year Died Vaccine Type ABDOMEN SCAN 2021 COVID19 VACCINE (COVID19) ABDOMEN SCAN 2021 Symptoms Total ABDOMEN SCAN ABDOMINAL DISCOMFORT 2021 ABDOMINAL DISCOMFORT 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL DISCOMFORT ABDOMINAL DISTENSION 2021 ABDOMINAL DISTENSION 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL DISTENSION ABDOMINAL EXPLORATION 2021 ABDOMINAL EXPLORATION 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL EXPLORATION ABDOMINAL HERNIA 2021 ABDOMINAL HERNIA 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL HERNIA ABDOMINAL INJURY 2021 ABDOMINAL INJURY 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL INJURY ABDOMINAL MASS 2021 ABDOMINAL MASS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL MASS ABDOMINAL PAIN 2021 ABDOMINAL PAIN 2021 ABDOMINAL PAIN Unknown Date ABDOMINAL PAIN Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN ABDOMINAL PAIN LOWER 2021 ABDOMINAL PAIN LOWER 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN LOWER ABDOMINAL PAIN UPPER 2021 ABDOMINAL PAIN UPPER 2021 ABDOMINAL PAIN UPPER Unknown Date ABDOMINAL PAIN UPPER Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN UPPER ABDOMINAL SEPSIS 2021 ABDOMINAL SEPSIS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL SEPSIS ABDOMINAL TENDERNESS 2021 ABDOMINAL TENDERNESS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL TENDERNESS ABDOMINAL WALL HAEMATOMA 2021 ABDOMINAL WALL HAEMATOMA 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL WALL HAEMATOMA ABDOMINAL WALL HAEMORRHAGE 2021 ABDOMINAL WALL HAEMORRHAGE 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL WALL HAEMORRHAGE ABDOMINAL WALL OEDEMA Total 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 1 0.01% 29 0.42% 29 0.42% 29 0.42% 26 0.37% 26 0.37% 26 0.37% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 115 1.65% 115 1.65% 3 0.04% 3 0.04% 118 1.69% 11 0.16% 11 0.16% 11 0.16% 57 0.82% 57 0.82% 5 0.07% 5 0.07% 62 0.89% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 3 0.04% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Symptoms ABDOMINAL WALL OEDEMA Year Died Vaccine Type Total 2021 Total ABDOMINAL WALL OEDEMA ABDOMINAL X-RAY 2021 ABDOMINAL X-RAY 2021 ABDOMINAL X-RAY Unknown Date ABDOMINAL X-RAY Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL X-RAY ABNORMAL BEHAVIOUR 2021 ABNORMAL BEHAVIOUR 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL BEHAVIOUR ABNORMAL FAECES 2021 ABNORMAL FAECES 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL FAECES ABNORMAL SLEEP-RELATED EVENT 2021 ABNORMAL SLEEP-RELATED EVENT 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL SLEEP-RELATED EVENT ABSCESS DRAINAGE 2021 ABSCESS DRAINAGE 2021 COVID19 VACCINE (COVID19) Total Total ABSCESS DRAINAGE ABSCESS LIMB 2021 ABSCESS LIMB 2021 COVID19 VACCINE (COVID19) Total Total ABSCESS LIMB ABSENCE OF IMMEDIATE TREATMENT RESPONSE 2021 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 2021 COVID19 VACCINE (COVID19) Total Total ABSENCE OF IMMEDIATE TREATMENT RESPONSE ABSTAINS FROM ALCOHOL 2021 ABSTAINS FROM ALCOHOL 2021 COVID19 VACCINE (COVID19) Total Total ABSTAINS FROM ALCOHOL ACCIDENT 2021 ACCIDENT 2021 COVID19 VACCINE (COVID19) Total Total ACCIDENT ACCIDENTAL OVERDOSE 2021 ACCIDENTAL OVERDOSE 2021 ACCIDENTAL OVERDOSE Unknown Date ACCIDENTAL OVERDOSE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACCIDENTAL OVERDOSE ACIDOSIS 2021 ACIDOSIS 2021 COVID19 VACCINE (COVID19) Total Total ACIDOSIS ACQUIRED OESOPHAGEAL WEB 2021 ACQUIRED OESOPHAGEAL WEB 2021 COVID19 VACCINE (COVID19) Total Total ACQUIRED OESOPHAGEAL WEB ACTIVATED PARTIAL THROMBOPLASTIN TIME 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME 2021 COVID19 VACCINE (COVID19) Total Total ACTIVATED PARTIAL THROMBOPLASTIN TIME ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 7 0.10% 7 0.10% 4 0.06% 4 0.06% 11 0.16% 29 0.42% 29 0.42% 29 0.42% 3 0.04% 3 0.04% 3 0.04% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 6 0.09% 6 0.09% 6 0.09% 1 0.01% 1 0.01% 1 0.01% 3 0.04% 3 0.04% 3 0.04% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 4 0.06% 19 0.27% 19 0.27% 19 0.27% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 7 0.10% 7 0.10% 2/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Symptoms Year Died ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED Vaccine Type Total ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED COVID19 VACCINE (COVID19) Total Total ACUTE ABDOMEN 2021 ACUTE ABDOMEN 2021 COVID19 VACCINE (COVID19) Total Total ACUTE ABDOMEN ACUTE CARDIAC EVENT 2021 ACUTE CARDIAC EVENT 2021 ACUTE CARDIAC EVENT Unknown Date ACUTE CARDIAC EVENT Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE CARDIAC EVENT ACUTE CHEST SYNDROME 2021 ACUTE CHEST SYNDROME 2021 COVID19 VACCINE (COVID19) Total Total ACUTE CHEST SYNDROME ACUTE CORONARY SYNDROME 2021 ACUTE CORONARY SYNDROME 2021 COVID19 VACCINE (COVID19) Total Total ACUTE CORONARY SYNDROME ACUTE HEPATIC FAILURE 2021 ACUTE HEPATIC FAILURE 2021 COVID19 VACCINE (COVID19) Total Total ACUTE HEPATIC FAILURE ACUTE INTERSTITIAL PNEUMONITIS 2021 ACUTE INTERSTITIAL PNEUMONITIS 2021 COVID19 VACCINE (COVID19) Total Total ACUTE INTERSTITIAL PNEUMONITIS ACUTE KIDNEY INJURY 2021 ACUTE KIDNEY INJURY 2021 ACUTE KIDNEY INJURY Unknown Date ACUTE KIDNEY INJURY Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE KIDNEY INJURY ACUTE LEFT VENTRICULAR FAILURE 2021 ACUTE LEFT VENTRICULAR FAILURE 2021 ACUTE LEFT VENTRICULAR FAILURE Unknown Date ACUTE LEFT VENTRICULAR FAILURE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE LEFT VENTRICULAR FAILURE ACUTE MYELOID LEUKAEMIA 2021 ACUTE MYELOID LEUKAEMIA 2021 COVID19 VACCINE (COVID19) Total Total ACUTE MYELOID LEUKAEMIA ACUTE MYOCARDIAL INFARCTION 2021 ACUTE MYOCARDIAL INFARCTION 2021 ACUTE MYOCARDIAL INFARCTION Unknown Date ACUTE MYOCARDIAL INFARCTION Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE MYOCARDIAL INFARCTION ACUTE PULMONARY OEDEMA 2021 ACUTE PULMONARY OEDEMA 2021 COVID19 VACCINE (COVID19) Total Total ACUTE PULMONARY OEDEMA ACUTE RESPIRATORY DISTRESS SYNDROME 2021 ACUTE RESPIRATORY DISTRESS SYNDROME 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 7 0.10% 10 0.14% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 1 0.01% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 11 0.16% 2 0.03% 2 0.03% 2 0.03% 9 0.13% 9 0.13% 9 0.13% 8 0.11% 8 0.11% 8 0.11% 1 0.01% 1 0.01% 1 0.01% 267 3.82% 267 3.82% 9 0.13% 9 0.13% 276 3.95% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 11 0.16% 9 0.13% 9 0.13% 9 0.13% 104 1.49% 104 1.49% 5 0.07% 5 0.07% 109 1.56% 4 0.06% 4 0.06% 4 0.06% 64 0.92% 64 0.92% 3/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Year Died Vaccine Type ACUTE RESPIRATORY DISTRESS SYNDROME Unknown Date COVID19 VACCINE (COVID19) ACUTE RESPIRATORY DISTRESS SYNDROME Unknown Date Symptoms Total Total ACUTE RESPIRATORY DISTRESS SYNDROME ACUTE RESPIRATORY FAILURE 2021 ACUTE RESPIRATORY FAILURE 2021 ACUTE RESPIRATORY FAILURE Unknown Date ACUTE RESPIRATORY FAILURE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE RESPIRATORY FAILURE ACUTE SINUSITIS 2021 ACUTE SINUSITIS 2021 COVID19 VACCINE (COVID19) Total Total ACUTE SINUSITIS ADAMTS13 ACTIVITY NORMAL 2021 ADAMTS13 ACTIVITY NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ADAMTS13 ACTIVITY NORMAL ADENOCARCINOMA 2021 ADENOCARCINOMA 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA ADENOCARCINOMA METASTATIC 2021 ADENOCARCINOMA METASTATIC 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA METASTATIC ADENOCARCINOMA OF COLON 2021 ADENOCARCINOMA OF COLON 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA OF COLON ADENOVIRUS TEST 2021 ADENOVIRUS TEST 2021 COVID19 VACCINE (COVID19) Total Total ADENOVIRUS TEST ADJUSTED CALCIUM 2021 ADJUSTED CALCIUM 2021 COVID19 VACCINE (COVID19) Total Total ADJUSTED CALCIUM ADRENAL HAEMORRHAGE 2021 ADRENAL HAEMORRHAGE 2021 COVID19 VACCINE (COVID19) Total Total ADRENAL HAEMORRHAGE ADULT FAILURE TO THRIVE 2021 ADULT FAILURE TO THRIVE 2021 COVID19 VACCINE (COVID19) Total Total ADULT FAILURE TO THRIVE ADVERSE DRUG REACTION Unknown Date ADVERSE DRUG REACTION Unknown Date COVID19 VACCINE (COVID19) Total Total ADVERSE DRUG REACTION ADVERSE EVENT 2021 ADVERSE EVENT 2021 ADVERSE EVENT Unknown Date ADVERSE EVENT Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ADVERSE EVENT ADVERSE EVENT FOLLOWING IMMUNISATION 2021 ADVERSE EVENT FOLLOWING IMMUNISATION 2021 COVID19 VACCINE (COVID19) Total Total ADVERSE EVENT FOLLOWING IMMUNISATION ADVERSE REACTION Unknown Date ADVERSE REACTION Unknown Date ADVERSE REACTION https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Total Events Reported Percent (of 6,981) 4 0.06% 4 0.06% 68 0.97% 255 3.65% 255 3.65% 4 0.06% 4 0.06% 259 3.71% 2 0.03% 2 0.03% 2 0.03% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 3 0.04% 8 0.11% 8 0.11% 8 0.11% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 4 0.06% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 4/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Year Died Vaccine Type AFFECT LABILITY 2021 COVID19 VACCINE (COVID19) AFFECT LABILITY 2021 Symptoms Total Total AFFECT LABILITY AGEUSIA 2021 AGEUSIA 2021 AGEUSIA Unknown Date AGEUSIA Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total AGEUSIA AGGRESSION 2021 AGGRESSION 2021 COVID19 VACCINE (COVID19) Total Total AGGRESSION AGITATION 2021 AGITATION 2021 COVID19 VACCINE (COVID19) Total Total AGITATION AGONAL DEATH STRUGGLE 2021 AGONAL DEATH STRUGGLE 2021 COVID19 VACCINE (COVID19) Total Total AGONAL DEATH STRUGGLE AGONAL RESPIRATION 2021 AGONAL RESPIRATION 2021 COVID19 VACCINE (COVID19) Total Total AGONAL RESPIRATION AGONAL RHYTHM 2021 AGONAL RHYTHM 2021 COVID19 VACCINE (COVID19) Total Total AGONAL RHYTHM AIRWAY PATENCY DEVICE INSERTION 2021 AIRWAY PATENCY DEVICE INSERTION 2021 COVID19 VACCINE (COVID19) Total Total AIRWAY PATENCY DEVICE INSERTION AIRWAY SECRETION CLEARANCE THERAPY 2021 AIRWAY SECRETION CLEARANCE THERAPY 2021 COVID19 VACCINE (COVID19) Total Total AIRWAY SECRETION CLEARANCE THERAPY ALANINE AMINOTRANSFERASE 2021 ALANINE AMINOTRANSFERASE 2021 ALANINE AMINOTRANSFERASE Unknown Date ALANINE AMINOTRANSFERASE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE ALANINE AMINOTRANSFERASE DECREASED 2021 ALANINE AMINOTRANSFERASE DECREASED 2021 COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE DECREASED ALANINE AMINOTRANSFERASE INCREASED 2021 ALANINE AMINOTRANSFERASE INCREASED 2021 ALANINE AMINOTRANSFERASE INCREASED Unknown Date ALANINE AMINOTRANSFERASE INCREASED Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE INCREASED ALANINE AMINOTRANSFERASE NORMAL 2021 ALANINE AMINOTRANSFERASE NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE NORMAL ALBUMIN GLOBULIN RATIO 2021 ALBUMIN GLOBULIN RATIO 2021 COVID19 VACCINE (COVID19) Total Total ALBUMIN GLOBULIN RATIO ALBUMIN GLOBULIN RATIO ABNORMAL 2021 ALBUMIN GLOBULIN RATIO ABNORMAL 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 1 0.01% 24 0.34% 24 0.34% 1 0.01% 1 0.01% 25 0.36% 9 0.13% 9 0.13% 9 0.13% 24 0.34% 24 0.34% 24 0.34% 1 0.01% 1 0.01% 1 0.01% 22 0.32% 22 0.32% 22 0.32% 5 0.07% 5 0.07% 5 0.07% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 1 0.01% 1 0.01% 4 0.06% 2 0.03% 2 0.03% 2 0.03% 38 0.54% 38 0.54% 1 0.01% 1 0.01% 39 0.56% 17 0.24% 17 0.24% 17 0.24% 3 0.04% 3 0.04% 3 0.04% 1 0.01% 1 0 01% 5/179

https://www.fichier-pdf.fr/2021/09/28/the-vaccine-adverse-event-reporting-system-vaers-results-form-1/

28/09/2021 www.fichier-pdf.fr



95% - AAenAKIUCI

Amino Acid Requirements in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy Imad F.

https://www.fichier-pdf.fr/2013/03/16/aaenakiuci/

16/03/2013 www.fichier-pdf.fr



93% - Management of acute asthma exacerbations

COPE-D-17-00008 REVIEW URRENT C OPINION Management of acute asthma exacerbations Erin K.

https://www.fichier-pdf.fr/2017/07/28/management-of-acute-asthma-exacerbations/

28/07/2017 www.fichier-pdf.fr



93% - https www.cps

Acute management of croup in the emergency department | Canadian Paediatric Soci...

https://www.fichier-pdf.fr/2017/11/26/https-www-cps/

26/11/2017 www.fichier-pdf.fr



93% - s.d.s Tecsit Hydrosil (FRA)[2132] FT

- 1≤x<5 Acute Tox.

https://www.fichier-pdf.fr/2019/09/19/sds-tecsit-hydrosil-fra2132-ft/

19/09/2019 www.fichier-pdf.fr



93% - Acute Kidney Injury in Pediatric Patients

Acute Kidney Injury in Pediatric Patients:

https://www.fichier-pdf.fr/2017/09/15/acute-kidney-injury-in-pediatric-patients/

15/09/2017 www.fichier-pdf.fr



90% - SANICLIP URIWAVE - FDS

2 H411 Acute Tox.

https://www.fichier-pdf.fr/2016/07/01/saniclip-uriwave-fds/

01/07/2016 www.fichier-pdf.fr



90% - Acute Decomp Heart Failure

Acute Decompensated Heart Failure:

https://www.fichier-pdf.fr/2017/08/03/acute-decomp-heart-failure/

03/08/2017 www.fichier-pdf.fr



90% - Asthma treatment

To describe and compare the treatment of acute asthma exacerbations in children seen in the emergency department (ED) and admitted to acute care floor in the hospital or intensive care unit (ICU).

https://www.fichier-pdf.fr/2017/10/01/asthma-treatment/

01/10/2017 www.fichier-pdf.fr



89% - jsc120003 2526 2533 (1)

SPECIAL COMMUNICATION ONLINE FIRST Acute Respiratory Distress Syndrome The Berlin Definition The ARDS Definition Task Force* V ALID AND RELIABLE DEFINI - tions are essential to conduct epidemiological studies succ e s s f u lly a n d t o facilitate enrollment of a consistent patient phenotype into clinical trials.1 Clinicians also need such definitions to implement the results of clinical trials, discuss prognosis with families, and plan resource allocation.

https://www.fichier-pdf.fr/2013/01/30/jsc120003-2526-2533-1/

30/01/2013 www.fichier-pdf.fr



88% - 7-Spielewoy-Psychopharm 2001

Psychopharmacology (2001) 159:2–9 DOI 10.1007/s002130100901 O R I G I N A L I N V E S T I G AT I O N Cécile Spielewoy · Grazyna Biala · Christine Roubert Michel Hamon · Catalina Betancur · Bruno Giros Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter Received:

https://www.fichier-pdf.fr/2011/09/28/7-spielewoy-psychopharm-2001/

28/09/2011 www.fichier-pdf.fr



88% - Virkon LSP MSDS

25 Acute Tox. ... H412 Acute Tox. ... H302 Acute Tox.

https://www.fichier-pdf.fr/2020/04/09/virkon-lsp-msds/

09/04/2020 www.fichier-pdf.fr



88% - PR Niger Enquête nutrition (Sept 2013) ENG

Despite aDUgood agricultural pastoral season, more than 13 in 100 children are suffering from acute malnutrition, the National Nutrition Survey shows.

https://www.fichier-pdf.fr/2013/09/05/pr-niger-enquete-nutrition-sept-2013-eng/

05/09/2013 www.fichier-pdf.fr



87% - hexanios

Toxicité aiguë pour le milieu aquatique, Catégorie 1 (Aquatic Acute 1, H400).

https://www.fichier-pdf.fr/2017/11/09/hexanios/

09/11/2017 www.fichier-pdf.fr



87% - biblio covid19 4

BIBLIOGRAPHIE RECHERCHE COVID 19 NEPHROLOGIE 25 MARS 2020 PR ALEXANDRE KARRAS, DR AURELIEN LORTHIOIR, DR OLIVIA LENOIR, PR PATRICK BRUNEVAL, HÔPITAL EUROPEEN GEORGES POMPIDOU JOURNAL TITRE PRINCIPALE POINTS CLES AUTEUR Bo Diao MedRxiv 4th March 2020 QUESTION Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2) Infection - 27.06% (23/85) patients exhibited acute renal Is the kidney a target of SARS failure (ARF).

https://www.fichier-pdf.fr/2020/03/26/bibliocovid194/

26/03/2020 www.fichier-pdf.fr



86% - capireesami

Valori superiori a quelli di riferimento possono essere determinati da brucellosi, da insufficienza renale cronica, da ittero ostruttivo, da leucemie acute, da neoplasie maligne, da reumatismo articolare acuto, da sepsi, da traumi, da ustioni.

https://www.fichier-pdf.fr/2012/05/30/capireesami/

30/05/2012 www.fichier-pdf.fr



86% - keratex hoof hardener

Acute Tox. 4 - H302;Acute Tox.

https://www.fichier-pdf.fr/2019/04/25/keratex-hoof-hardener/

25/04/2019 www.fichier-pdf.fr



85% - AVC kiné précoce, quel contenu, proposition d'un contenu kinésithérapique en phase aigue J1 à J14

Proposal of a Physiotherapy Content in Acute Phase (D1 to D14), part I.

https://www.fichier-pdf.fr/2021/05/07/avc-kine-precoce-quel-contenu-proposition-dun-contenu-kinesither/

07/05/2021 www.fichier-pdf.fr



85% - ANIOSURF ND PREMIUM FRAICHEUR - FDS

Toxicité aiguë pour le milieu aquatique, Catégorie 1 (Aquatic Acute 1, H400).

https://www.fichier-pdf.fr/2016/06/30/aniosurf-nd-premium-fraicheur-fds/

30/06/2016 www.fichier-pdf.fr



83% - BACTERANIOS SF - FDS

Toxicité aiguë par voie orale, Catégorie 4 (Acute Tox.

https://www.fichier-pdf.fr/2016/06/30/bacteranios-sf-fds/

30/06/2016 www.fichier-pdf.fr



83% - gold

goldl@u.washington.edu The study was supported in part by a grant from the Laerdal Foundation of Acute Medicine.

https://www.fichier-pdf.fr/2012/04/02/gold/

02/04/2012 www.fichier-pdf.fr



83% - Oral corticosteroids and acute respiratory diseases

Italian Journal of Pediatrics (2017) 43:31 DOI 10.1186/s13052-017-0348-x REVIEW Open Access Management of acute respiratory diseases in the pediatric population:

https://www.fichier-pdf.fr/2017/11/26/oral-corticosteroids-and-acute-respiratory-diseases/

26/11/2017 www.fichier-pdf.fr



83% - DEGRAGERM QS - FDS

1B (H314) Acute Tox.

https://www.fichier-pdf.fr/2016/07/01/degragerm-qs-fds/

01/07/2016 www.fichier-pdf.fr



83% - Acute cerebellitis- eleven year retrospective study

Italian Journal of Pediatrics (2017) 43:54 DOI 10.1186/s13052-017-0370-z RESEARCH Open Access Acute cerebellitis in children:

https://www.fichier-pdf.fr/2017/11/27/acute-cerebellitis-eleven-year-retrospective-study/

27/11/2017 www.fichier-pdf.fr